Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corneal Neovascularization | 8 | 2019 | 185 | 3.490 |
Why?
|
| Cornea | 5 | 2023 | 1326 | 1.220 |
Why?
|
| Capillaries | 2 | 2018 | 744 | 0.910 |
Why?
|
| Neovascularization, Pathologic | 5 | 2021 | 2638 | 0.870 |
Why?
|
| Basement Membrane | 2 | 2021 | 348 | 0.850 |
Why?
|
| Pericytes | 2 | 2022 | 293 | 0.720 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2019 | 2047 | 0.690 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2022 | 3480 | 0.680 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2018 | 16 | 0.620 |
Why?
|
| Dexamethasone | 4 | 2023 | 1927 | 0.560 |
Why?
|
| Endothelial Cells | 5 | 2023 | 3533 | 0.530 |
Why?
|
| Rats, Wistar | 5 | 2019 | 1844 | 0.500 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2023 | 1795 | 0.420 |
Why?
|
| Receptors, CXCR5 | 2 | 2020 | 88 | 0.340 |
Why?
|
| Macular Degeneration | 4 | 2021 | 1001 | 0.330 |
Why?
|
| Rats | 8 | 2019 | 23681 | 0.310 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 11893 | 0.310 |
Why?
|
| Gene Expression | 2 | 2019 | 7584 | 0.290 |
Why?
|
| Cell Movement | 1 | 2019 | 5201 | 0.290 |
Why?
|
| Inflammation | 6 | 2023 | 10718 | 0.280 |
Why?
|
| NF-kappa B | 3 | 2021 | 2472 | 0.280 |
Why?
|
| Retina | 4 | 2022 | 2637 | 0.280 |
Why?
|
| Retinal Degeneration | 2 | 2020 | 412 | 0.250 |
Why?
|
| Keratitis | 2 | 2018 | 239 | 0.240 |
Why?
|
| Retinal Vessels | 2 | 2020 | 836 | 0.230 |
Why?
|
| Signal Transduction | 8 | 2021 | 23342 | 0.230 |
Why?
|
| Microglia | 3 | 2021 | 1349 | 0.220 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2021 | 301 | 0.220 |
Why?
|
| MicroRNAs | 1 | 2019 | 3782 | 0.210 |
Why?
|
| Animals | 21 | 2023 | 167777 | 0.190 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 1267 | 0.180 |
Why?
|
| Keratoconus | 1 | 2022 | 110 | 0.180 |
Why?
|
| Blood-Retinal Barrier | 1 | 2020 | 62 | 0.180 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18123 | 0.180 |
Why?
|
| Photoreceptor Cells | 1 | 2020 | 236 | 0.160 |
Why?
|
| Genome | 2 | 2017 | 1739 | 0.160 |
Why?
|
| Calcium Channels, L-Type | 1 | 2020 | 240 | 0.160 |
Why?
|
| Zebrafish | 4 | 2021 | 2992 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 694 | 0.140 |
Why?
|
| PPAR alpha | 1 | 2018 | 175 | 0.140 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 250 | 0.140 |
Why?
|
| Collagen | 2 | 2023 | 2634 | 0.130 |
Why?
|
| Receptors, Chemokine | 1 | 2019 | 655 | 0.130 |
Why?
|
| Eye Proteins | 1 | 2018 | 633 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1788 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2016 | 745 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 869 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 1968 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 1957 | 0.100 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1740 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4342 | 0.100 |
Why?
|
| Benzamides | 1 | 2018 | 1367 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2019 | 1358 | 0.090 |
Why?
|
| Leukocytes | 1 | 2019 | 2025 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1842 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2495 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2145 | 0.080 |
Why?
|
| RNA | 1 | 2019 | 2716 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4429 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8426 | 0.080 |
Why?
|
| Rabbits | 2 | 2023 | 4771 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22008 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7339 | 0.060 |
Why?
|
| Angiopoietins | 1 | 2022 | 84 | 0.050 |
Why?
|
| Corneal Topography | 1 | 2022 | 68 | 0.050 |
Why?
|
| Refraction, Ocular | 1 | 2022 | 179 | 0.050 |
Why?
|
| Male | 8 | 2020 | 358227 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2021 | 211 | 0.040 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2019 | 24 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15773 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2022 | 1339 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 453 | 0.040 |
Why?
|
| Electroretinography | 1 | 2020 | 517 | 0.040 |
Why?
|
| Hydrogels | 1 | 2023 | 723 | 0.040 |
Why?
|
| Xanthophylls | 1 | 2017 | 94 | 0.040 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 357 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 695 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 597 | 0.030 |
Why?
|
| Lasers | 1 | 2021 | 951 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 785 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 544 | 0.030 |
Why?
|
| Data Mining | 1 | 2021 | 551 | 0.030 |
Why?
|
| Mice | 5 | 2021 | 81107 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 757650 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 696 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 611 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2470 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 961 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18941 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14354 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1066 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 1133 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2774 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 1111 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 1553 | 0.030 |
Why?
|
| Autophagy | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 1076 | 0.030 |
Why?
|
| Swine | 1 | 2022 | 5892 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2022 | 1870 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9404 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1044 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1737 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2020 | 6231 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4336 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 3995 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3774 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 3826 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15594 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22024 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39018 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54108 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58559 | 0.010 |
Why?
|
| Female | 2 | 2022 | 389985 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 167889 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 219747 | 0.000 |
Why?
|
Concepts
(115)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_